{"entity":{"type":"insider","cik":"0001865131","url":"/insider/0001865131","json_url":"/insider/0001865131.json","name":"Seshadri Vishwas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":13,"first":"2023-09-29","last":"2026-07-09","span_basis":"filed_date"},"name_variants":[{"name":"Seshadri Vishwas","source":"filing","n_filings":13,"first_seen":"2023-09-29","last_seen":"2026-07-09"}],"transactions":[{"id":5881562,"accession":"0001493152-26-032744","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-032744","line_url":"/filing/0001493152-26-032744#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001865131","owner_name":"Seshadri Vishwas","owner_display_name":"Seshadri Vishwas","owner_url":"/insider/0001865131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67971.0,"shares_display":"67,971","price_per_share":6.9637,"price_display":"6.96","price_state":"stated","total_value":473329.6527,"total_display":"473,329.65","total_whole":"473,330","shares_owned_after":1306108.0,"shares_owned_after_display":"1,306,108","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-09","filed_date":"2026-07-09","scope":"insider"},{"id":5916657,"accession":"0001493152-26-028020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-26-028020","line_url":"/filing/0001493152-26-028020#line-2","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001865131","owner_name":"Seshadri Vishwas","owner_display_name":"Seshadri Vishwas","owner_url":"/insider/0001865131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31916.0,"shares_display":"31,916","price_per_share":5.3042,"price_display":"5.30","price_state":"stated","total_value":169288.8472,"total_display":"169,288.85","total_whole":"169,289","shares_owned_after":1374079.0,"shares_owned_after_display":"1,374,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-09","filed_date":"2026-06-09","scope":"insider"},{"id":5916654,"accession":"0001493152-26-028020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-028020","line_url":"/filing/0001493152-26-028020#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001865131","owner_name":"Seshadri Vishwas","owner_display_name":"Seshadri Vishwas","owner_url":"/insider/0001865131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24428.0,"shares_display":"24,428","price_per_share":5.4295,"price_display":"5.43","price_state":"stated","total_value":132631.826,"total_display":"132,631.83","total_whole":"132,632","shares_owned_after":1405995.0,"shares_owned_after_display":"1,405,995","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-08","filed_date":"2026-06-09","scope":"insider"},{"id":5740453,"accession":"0001493152-26-014418","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-014418","line_url":"/filing/0001493152-26-014418#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001865131","owner_name":"Seshadri Vishwas","owner_display_name":"Seshadri Vishwas","owner_url":"/insider/0001865131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29985.0,"shares_display":"29,985","price_per_share":4.3849,"price_display":"4.38","price_state":"stated","total_value":131481.2265,"total_display":"131,481.23","total_whole":"131,481","shares_owned_after":1430423.0,"shares_owned_after_display":"1,430,423","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-31","filed_date":"2026-03-31","scope":"insider"},{"id":6185585,"accession":"0001493152-26-003283","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-003283","line_url":"/filing/0001493152-26-003283#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001865131","owner_name":"Seshadri Vishwas","owner_display_name":"Seshadri Vishwas","owner_url":"/insider/0001865131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69832.0,"shares_display":"69,832","price_per_share":5.3309,"price_display":"5.33","price_state":"stated","total_value":372267.4088,"total_display":"372,267.41","total_whole":"372,267","shares_owned_after":1460408.0,"shares_owned_after_display":"1,460,408","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-22","scope":"insider"},{"id":4120302,"accession":"0001493152-25-029384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-029384","line_url":"/filing/0001493152-25-029384#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001865131","owner_name":"Seshadri Vishwas","owner_display_name":"Seshadri Vishwas","owner_url":"/insider/0001865131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":5.3096,"price_display":"5.31","price_state":"stated","total_value":132740.0,"total_display":"132,740.00","total_whole":"132,740","shares_owned_after":1164818.0,"shares_owned_after_display":"1,164,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-29","filed_date":"2025-12-29","scope":"insider"},{"id":4152088,"accession":"0001493152-25-018311","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-018311","line_url":"/filing/0001493152-25-018311#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001865131","owner_name":"Seshadri Vishwas","owner_display_name":"Seshadri Vishwas","owner_url":"/insider/0001865131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":249.0,"shares_display":"249","price_per_share":5.485,"price_display":"5.48","price_state":"stated","total_value":1365.765,"total_display":"1,365.76","total_whole":"1,366","shares_owned_after":1189818.0,"shares_owned_after_display":"1,189,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-16","filed_date":"2025-10-16","scope":"insider"},{"id":4217946,"accession":"0001493152-25-016543","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-25-016543","line_url":"/filing/0001493152-25-016543#line-2","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001865131","owner_name":"Seshadri Vishwas","owner_display_name":"Seshadri Vishwas","owner_url":"/insider/0001865131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":5.2372,"price_display":"5.24","price_state":"stated","total_value":130930.0,"total_display":"130,930.00","total_whole":"130,930","shares_owned_after":1190067.0,"shares_owned_after_display":"1,190,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-30","filed_date":"2025-10-01","scope":"insider"},{"id":4217941,"accession":"0001493152-25-016543","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-016543","line_url":"/filing/0001493152-25-016543#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001865131","owner_name":"Seshadri Vishwas","owner_display_name":"Seshadri Vishwas","owner_url":"/insider/0001865131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19274.0,"shares_display":"19,274","price_per_share":5.3935,"price_display":"5.39","price_state":"stated","total_value":103954.319,"total_display":"103,954.32","total_whole":"103,954","shares_owned_after":1215067.0,"shares_owned_after_display":"1,215,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-29","filed_date":"2025-10-01","scope":"insider"},{"id":4774338,"accession":"0001641172-25-018606","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-018606","line_url":"/filing/0001641172-25-018606#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001865131","owner_name":"Seshadri Vishwas","owner_display_name":"Seshadri Vishwas","owner_url":"/insider/0001865131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69420.0,"shares_display":"69,420","price_per_share":5.8557,"price_display":"5.86","price_state":"stated","total_value":406502.694,"total_display":"406,502.69","total_whole":"406,503","shares_owned_after":1234341.0,"shares_owned_after_display":"1,234,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-09","filed_date":"2025-07-10","scope":"insider"},{"id":5175045,"accession":"0001641172-25-014172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-014172","line_url":"/filing/0001641172-25-014172#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001865131","owner_name":"Seshadri Vishwas","owner_display_name":"Seshadri Vishwas","owner_url":"/insider/0001865131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50676.0,"shares_display":"50,676","price_per_share":6.76,"price_display":"6.76","price_state":"stated","total_value":342569.76,"total_display":"342,569.76","total_whole":"342,570","shares_owned_after":1303761.0,"shares_owned_after_display":"1,303,761","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-06","filed_date":"2025-06-06","scope":"insider"},{"id":4996290,"accession":"0001641172-25-001922","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-001922","line_url":"/filing/0001641172-25-001922#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001865131","owner_name":"Seshadri Vishwas","owner_display_name":"Seshadri Vishwas","owner_url":"/insider/0001865131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":4.78,"price_display":"4.78","price_state":"stated","total_value":119500.0,"total_display":"119,500.00","total_whole":"119,500","shares_owned_after":1355322.0,"shares_owned_after_display":"1,355,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-31","filed_date":"2025-03-31","scope":"insider"},{"id":2506391,"accession":"0001493152-24-016853","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-016853","line_url":"/filing/0001493152-24-016853#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001865131","owner_name":"Seshadri Vishwas","owner_display_name":"Seshadri Vishwas","owner_url":"/insider/0001865131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":32000.0,"total_display":"32,000.00","total_whole":"32,000","shares_owned_after":538260.0,"shares_owned_after_display":"538,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-25","filed_date":"2024-04-29","scope":"insider"},{"id":2867108,"accession":"0001493152-24-005208","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-005208","line_url":"/filing/0001493152-24-005208#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001865131","owner_name":"Seshadri Vishwas","owner_display_name":"Seshadri Vishwas","owner_url":"/insider/0001865131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":4.39,"price_display":"4.39","price_state":"stated","total_value":87800.0,"total_display":"87,800.00","total_whole":"87,800","shares_owned_after":528260.0,"shares_owned_after_display":"528,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-06","filed_date":"2024-02-07","scope":"insider"},{"id":8037563,"accession":"0001493152-23-034741","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-034741","line_url":"/filing/0001493152-23-034741#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ABEONA THERAPEUTICS INC.","issuer_ticker":"ABEO","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":"0001865131","owner_name":"Seshadri Vishwas","owner_display_name":"Seshadri Vishwas","owner_url":"/insider/0001865131","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":4.07,"price_display":"4.07","price_state":"stated","total_value":81400.0,"total_display":"81,400.00","total_whole":"81,400","shares_owned_after":521731.0,"shares_owned_after_display":"521,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-27","filed_date":"2023-09-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000318306","name":"ABEONA THERAPEUTICS INC.","url":"/issuer/0000318306","role":"Director, Officer (Chief Executive Officer)","n_filings":13,"first_seen":"2023-09-29","last_seen":"2026-07-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001865131","retrieved_at":"2026-08-25T20:08:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}